AAREYDRUGS.NSAAREYDRUGS.NSNSE
Loading
Year-over-year earnings per share growth rate
Percentile
P15
Within normal range
vs 2Y Ago
-0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -44.44% |
| Q3 2025 | -25.00% |
| Q2 2025 | 182.35% |
| Q1 2025 | -34.62% |
| Q4 2024 | -54.39% |
| Q3 2024 | 29.55% |
| Q2 2024 | -42.86% |
| Q1 2024 | 2.67% |
| Q4 2023 | 141.94% |
| Q3 2023 | 6.90% |
| Q2 2023 | 107.14% |
| Q1 2023 | -26.32% |
| Q4 2022 | -77.11% |
| Q3 2022 | 159.38% |
| Q2 2022 | 186.49% |
| Q1 2022 | -148.05% |
| Q4 2021 | -36.89% |
| Q3 2021 | 14.02% |
| Q2 2021 | 78.33% |
| Q1 2021 | -17.81% |
| Q4 2020 | -7.59% |
| Q3 2020 | 36.21% |
| Q2 2020 | 34.88% |
| Q1 2020 | -28.33% |
| Q4 2019 | 9.09% |
| Q3 2019 | -38.89% |
| Q2 2019 | 190.32% |
| Q1 2019 | -53.03% |
| Q4 2018 | -28.26% |
| Q3 2018 | 2.22% |
| Q2 2018 | 119.51% |
| Q1 2018 | -54.44% |
| Q4 2017 | 9.76% |
| Q3 2017 | -21.90% |
| Q2 2017 | 41.89% |
| Q1 2017 | -26.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 53.85% |
| Q2 2016 | 3150.00% |
| Q1 2016 | -83.33% |